Dynamic Contrast-Enhanced Magnetic Resonance Imaging
Showing 1 - 25 of >10,000
Hereditary Pancreatic Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Intraductal Papillary-Mucinous Tumor Trial in Portland
Recruiting
- Hereditary Pancreatic Carcinoma
- +2 more
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging
- Ferumoxytol
-
Portland, OregonOHSU Knight Cancer Institute
Aug 16, 2022
Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer Trial in New Brunswick (Arterial Spin
Completed
- Stage I Renal Cell Cancer
- +3 more
- Arterial Spin Labeling Magnetic Resonance Imaging
- +3 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Oct 14, 2022
Childhood Brain Tumor, Recurrent Childhood Brain Tumor Trial in Portland (Dynamic Contrast-Enhanced Magnetic Resonance Imaging,
Completed
- Childhood Brain Neoplasm
- Recurrent Childhood Brain Neoplasm
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging
- +3 more
-
Portland, OregonOHSU Knight Cancer Institute
Jul 11, 2022
Brain Metastases, Glioma of Brain, Brain Tumor Trial in Los Angeles (Dynamic Contrast-Enhanced Magnetic Resonance Imaging,
Recruiting
- Brain Metastases
- +3 more
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging
- Bevacizumab Injection
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Nov 12, 2022
Quantitative MRI Assessment of Breast Cancer Therapy Response
Recruiting
- Breast Cancer
- Diffusion Weighted Imaging
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging
-
Iowa City, Iowa
- +2 more
Jan 19, 2023
d to Predict Intra-arterial Chemotherapy Response in
Recruiting
- Retinoblastoma
- Dynamic contrast-enhanced MRI
-
Paris, FranceFondation A De Rothschild
Mar 18, 2022
Cervical Cancer Squamous Cell Trial in Toronto (18-FDG PET/CT, DWI, DCE-MRI)
Completed
- Cervical Cancer Squamous Cell
- 18-FDG PET/CT, DWI, DCE-MRI
-
Toronto, Ontario, CanadaUniversity Health Network, The Princess Margaret
Nov 7, 2022
Dynamic Contrast-enhanced MRI Combined With IVIM-DWI for Early
Recruiting
- Metastatic Breast Cancer in the Liver
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
Sep 23, 2022
Malignant Ovarian Tumor, Ovarian Carcinoma Trial in Houston (Dynamic Enhanced CT, Magnetic Resonance Imaging, Positron Emission
Recruiting
- Malignant Ovarian Neoplasm
- Ovarian Carcinoma
- Dynamic Enhanced CT
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 12, 2022
Brain Injuries, Cerebrovascular Disorders Trial in Loma Linda (DCE MRI of the brain)
Completed
- Brain Injuries
- Cerebrovascular Disorders
- DCE MRI of the brain
-
Loma Linda, CaliforniaLoma Linda University Medical Center
Jun 29, 2021
Metastatic Malignant Tumor in the Brain, Primary Brain Tumor Trial in Portland (3 Tesla Magnetic Resonance Imaging, Dynamic
Terminated
- Metastatic Malignant Neoplasm in the Brain
- Primary Brain Neoplasm
- 3 Tesla Magnetic Resonance Imaging
- +6 more
-
Portland, OregonOHSU Knight Cancer Institute
Nov 3, 2021
MRI and PET Imaging in Predicting Treatment Response in Stage
Active, not recruiting
- Cervical Adenocarcinoma
- +12 more
- Computed Tomography
- +5 more
-
Miami, Florida
- +5 more
Oct 4, 2022
Breast Cancer Trial in Nashville (diffusion-weighted magnetic resonance imaging, dynamic contrast-enhanced magnetic resonance
Active, not recruiting
- Breast Cancer
- diffusion-weighted magnetic resonance imaging
- +2 more
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Nov 22, 2021
BCLC Stage A Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma Trial in
Recruiting
- BCLC Stage A Hepatocellular Carcinoma
- +3 more
- 18F-Fluoromisonidazole
- +3 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
May 25, 2022
Glioblastoma Trial in Columbus, Portland (Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging, Ferumoxytol,
Completed
- Glioblastoma
- Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging
- +3 more
-
Columbus, Ohio
- +1 more
Mar 11, 2022
Estrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor Negative Trial in United States (procedure, other,
Active, not recruiting
- Estrogen Receptor Negative
- +3 more
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging
- +3 more
-
Houston, Texas
- +5 more
Feb 11, 2022
QSM and Regional DCE MRI Permeability Using GOCART Technique
Withdrawn
- Intracranial Neoplasm
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging
- +3 more
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Apr 1, 2021
Head Neck Cancer Trial in Houston (Magnetic Resonance Imaging (MRI), Ferumoxytol)
Terminated
- Head and Neck Cancer
- Magnetic Resonance Imaging (MRI)
- Ferumoxytol
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Sep 15, 2021
DCE-MRI for Assessment of Response to TACE of HCC
Completed
- Carcinoma, Hepatocellular
- Post-treatment phase group
- Pre-treatment phase group
-
Montreal, Quebec, CanadaCentre hospitalier de l'Université de Montréal
Aug 4, 2021
Head Neck Cancer Trial in Houston (Dynamic Contrast-Enhanced Magnetic Resonance Imaging, Questionnaire Administration)
Recruiting
- Head and Neck Cancer
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging
- Questionnaire Administration
-
Houston, TexasM D Anderson Cancer Center
Oct 29, 2020
18F-fluciclovine PET/MRI Imaging for Detection of Tumor
Suspended
- Metastatic Intracranial Malignant Neoplasm
- Recurrent Intracranial Neoplasm
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging with Positron Emission Tomography
- Fluciclovine F18
-
Jacksonville, FloridaMayo Clinic in Florida
Dec 27, 2021
Invasive Malignant Tumor, Metastatic Malignant Tumor in the Brain Trial in Atlanta (Dynamic Susceptibility Contrast-MRI
Recruiting
- Invasive Malignant Neoplasm
- Metastatic Malignant Neoplasm in the Brain
- Dynamic Susceptibility Contrast-MRI (DSC-MRI)
- Magnetic Resonance Imaging (MRI)
-
Atlanta, Georgia
- +1 more
Sep 1, 2021
Breast Cancer, Triple Negative Breast Cancer Trial in New York (Sodium (Na) Magnetic Resonance Imaging (MRI), Dynamic Contrast-
Terminated
- Breast Cancer
- Triple Negative Breast Cancer
- Sodium (Na) Magnetic Resonance Imaging (MRI)
- Dynamic Contrast- Enhanced (DCE) MRI
-
New York, New YorkNYU Langone Health
Aug 1, 2022
Breast Cancer Trial in Chapel Hill (Iohexol 350 Mg/mL Injectable Solution)
Recruiting
- Breast Cancer
- Iohexol 350 Mg/mL Injectable Solution
-
Chapel Hill, North CarolinaUniversity of North Carolina at Chapel Hill
Feb 21, 2023
Diabetes, Magnetic Resonance Imaging Trial in Beijing (Polysaccharide superparamagnetic iron oxide injection)
Completed
- Diabetes
- Magnetic Resonance Imaging
- Polysaccharide superparamagnetic iron oxide injection
-
Beijing, Beijing, ChinaBeijing Luhe Hospital, Capital Medical University
Sep 27, 2023